SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
HYLJ
Lv1
1
60 积分
2025-04-28 加入
最近求助
最近应助
互助留言
Explainable artificial intelligence for early prediction of pressure injury risk
7小时前
已完结
Identifying risk factors for pressure injury in adult critical care patients
7小时前
求助中
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018
7小时前
已采纳
First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study
7小时前
已采纳
感谢，速度真快
7小时前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018
First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study
皖公网安备34019202002308
